Loading Events

« All Events

  • This event has passed.

Ketamine 101: An Introduction to Ketamine-Assisted Psychotherapy [ONLINE]

April 9 @ 12:00 pm - 1:00 pm

by Portland Psychotherapy


April 9th, 2021 – Ketamine 101: An Introduction to Ketamine-Assisted Psychotherapy with Gregory Wells, Ph.D.

Ketamine-assisted psychotherapy (KAP) has recently emerged as one of the most innovative treatments for depression (particularly treatment-resistant depression (TRD), anxiety, post-traumatic stress disorder (PTSD) as well as a host of other psychological conditions. Integrating pharmacological, psychological, and archetypal/transpersonal elements, KAP represents a new synthesis (or hybrid model) of psychotherapy. Empirical results, particularly during the past decade, demonstrate that ketamine and KAP may be able to assist clinical populations whose symptoms and psychological issues have not been responsive to treatment by other means. At the same time, KAP holds promise for effective treatment of individuals with end-of-life anxiety, existential distress, and less severe diagnoses. The practice of KAP, including diverse dosing strategies, allows clinicians to craft intervention strategies at both the psycholytic (trance, self-reflective) and psychedelic (transformational/transpersonal) levels of experience. This short introductory course will cover a wide range of topics to help clinicians understand the potential use and efficacy of KAP, as well as other psychedelic medicines, and will present the current state of the art clinical models for these treatments. Recent promising lines of research in the field will also be briefly covered.

Gregory Wells (he/him/queer) is a licensed psychologist based in San Francisco. He is a clinician and researcher in the field of psychedelic medicine and a supporter of cognitive liberty and decriminalization. He obtained his doctorate degree from UT-Austin and also holds a post-doctoral degree in clinical psychopharmacology. He currently works as a principal investigator and therapist on the MAPS-sponsored Phase 3 clinical trial of MDMA-assisted psychotherapy to treat PTSD. He is also co-founder of Polaris Insight Center, a cutting edge ketamine-assisted psychotherapy clinic in SF. Gregory has a long-standing interest in and deep respect for plant medicines, entheogens, and indigenous and shamanic pracitces and he is eternally grateful for the lineage of healers, teachers, and ancestors who came before him and who make this work possible.




Portland Psychotherapy